The roles of the Hippo pathway in cancer metastasis

被引:93
|
作者
van Rensburg, Helena J. Janse [1 ]
Yang, Xiaolong [1 ]
机构
[1] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada
关键词
Hippo pathway; Tumour suppressor; Metastasis; EMT; Cell migration; Cancer; YES-ASSOCIATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; REGULATES CELL-PROLIFERATION; BREAST-CANCER; TUMOR-SUPPRESSOR; SIGNALING PATHWAY; UP-REGULATION; LUNG-CANCER; E-CADHERIN; TRANSCRIPTIONAL COACTIVATOR;
D O I
10.1016/j.cellsig.2016.08.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cancer metastasis refers to the sequence of events whereby tumour cells detach from their primary tissue, invade and migrate to nearby vasculature, intravasate into circulation, survive in circulation and extravasate at a distant site to establish a secondary tumour. Each step in this "metastatic cascade" is coordinated by complex molecular events that remain only incompletely understood. Given that the vast majority of cancer fatalities occur due to metastasis, there is an urgent need for an improved understanding of the specific mechanisms underlying cancer metastasis and for the development of therapeutics targeting this lethal process. The Hippo pathway is an emerging signaling pathway that plays important roles in development and disease. In cancer cells, dysregulation of the Hippo pathway drives multiple aspects of tumour initiation and progression. Recent studies have uncovered a role for the Hippo pathway core components in promoting cancer metastasis. In this review, we summarize the clinical and biochemical evidence implicating the Hippo pathway in metastasis. Additionally, we describe the molecular mechanisms by which aberrant Hippo signaling promotes metastasis. Finally, we highlight areas for future research. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1761 / 1772
页数:12
相关论文
共 50 条
  • [1] Roles of RUNX in Hippo Pathway Signaling
    Passaniti, Antonino
    Brusgard, Jessica L.
    Qiao, Yiting
    Sudol, Marius
    Finch-Edmondson, Megan
    RUNX PROTEINS IN DEVELOPMENT AND CANCER, 2017, 962 : 435 - 448
  • [2] Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
    Lin, Kimberly C.
    Park, Hyun Woo
    Guan, Kun-Liang
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2, 2018, 2 : 59 - 79
  • [3] Two faces of Hippo: activate or suppress the Hippo pathway in cancer
    Cao, Jingwen
    Huang, Wenlong
    ANTI-CANCER DRUGS, 2017, 28 (10) : 1079 - 1085
  • [4] Role of the Hippo Pathway in Fibrosis and Cancer
    Kim, Cho-Long
    Choi, Sue-Hee
    Mo, Jung-Soon
    CELLS, 2019, 8 (05)
  • [5] Hippo pathway and breast cancer stem cells
    Maugeri-Sacca, Marcello
    De Maria, Ruggero
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 99 : 115 - 122
  • [6] Targeting the Hippo Pathway for Breast Cancer Therapy
    Wu, Liqing
    Yang, Xiaolong
    CANCERS, 2018, 10 (11)
  • [7] New Horizons in Cancer Progression and Metastasis: Hippo Signaling Pathway
    Kuracha, Murali R.
    Radhakrishna, Uppala
    Kuracha, Sreenaga V.
    Vegi, Navyasri
    Gurung, Jhyama Lhamo
    Mcvicker, Benita L.
    BIOMEDICINES, 2024, 12 (11)
  • [8] The Hippo pathway in colorectal cancer
    Wierzbicki, Piotr M.
    Rybarczyk, Agnieszka
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2015, 53 (02) : 105 - 119
  • [9] Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective
    Samji, Priyanka
    Rajendran, Manoj K.
    Warrier, Vidya P.
    Ganesh, Akshayaa
    Devarajan, Karunagaran
    CELLULAR SIGNALLING, 2021, 78
  • [10] The role of Hippo signal pathway in breast cancer metastasis
    Wei, Changran
    Wang, Ying
    Li, Xiangqi
    ONCOTARGETS AND THERAPY, 2018, 11 : 2185 - 2193